tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO
US Market
Advertisement

Crescent Biopharma (CBIO) Technical Analysis

Compare
987 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Crescent Biopharma’s (CBIO) Moving Averages Convergence Divergence (MACD) indicator is -0.20, suggesting Crescent Biopharma is a Sell.
Crescent Biopharma’s (CBIO) 20-Day exponential moving average is 13.06, while Crescent Biopharma’s (CBIO) share price is $12.43, making it a Sell.
Crescent Biopharma’s (CBIO) 50-Day exponential moving average is 13.82, while Crescent Biopharma’s (CBIO) share price is $12.43, making it a Sell.

Crescent Biopharma (CBIO) Pivot Points

Sep 29, 2025, 02:31 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.17
12.46
12.70
12.99
13.23
13.52
13.76
Fibonacci
12.46
12.66
12.78
12.99
13.19
13.31
13.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crescent Biopharma (CBIO) Moving Averages

Sep 29, 2025, 02:31 PM
Period
Simple
Exponential
MA5
12.98Buy
12.94Buy
MA10
12.75Buy
12.92Buy
MA20
13.14Sell
13.06Sell
MA50
13.12Sell
13.82Sell
MA100
16.29Sell
15.94Sell
MA200
20.85Sell
20.00Sell
Crescent Biopharma’s (CBIO) 10-Day exponential moving average is 12.92, while Crescent Biopharma’s (CBIO) share price is $12.43, making it a Buy.
Crescent Biopharma’s (CBIO) 100-Day exponential moving average is 15.94, while Crescent Biopharma’s (CBIO) share price is $12.43, making it a Sell.
Crescent Biopharma’s (CBIO) stock price is $12.43 and Crescent Biopharma’s (CBIO) 50-day simple moving average is 13.12, creating a Sell signal.
Crescent Biopharma’s (CBIO) stock price is $12.43 and Crescent Biopharma’s (CBIO) 100-day simple moving average is 16.29, creating a Sell signal.
Crescent Biopharma’s (CBIO) stock price is $12.43 and Crescent Biopharma’s (CBIO) 200-day simple moving average is 20.85, creating a Sell signal.

Crescent Biopharma (CBIO) Technical Indicators

Sep 29, 2025, 02:31 PM
Name
Value
Implied Action
RSI (14)
47.62
Neutral
STOCH (9,6)
66.89
Neutral
STOCHRSI (14)
39.89
Neutral
MACD (12,26)
-0.20
Sell
ADX (14)
12.72
Buy
Williams %R
-61.46
Buy
CCI (14)
-18.65
Neutral
ATR (14)
0.83
-
Ultimate Oscillator
45.69
Neutral
ROC
-5.19
Sell
Crescent Biopharma’s (CBIO) Relative Strength Index (RSI) is 47.62, creating a Neutral signal.
Crescent Biopharma’s (CBIO) Trend Strength Indicator (ADX) is 12.72, creating a Buy signal.
Crescent Biopharma’s (CBIO) Commodity Channel Index (CCI) is -18.65, creating a Neutral signal.
Crescent Biopharma’s (CBIO) Price Rate of Change (ROC) is -5.19, creating a Sell signal.

FAQ

Is CBIO a Buy, Hold, or Sell?
Based on CBIO’s technical indicators, CBIO is a Sell.
    What is CBIO’s RSI (14)?
    CBIO’s RSI (14) is 47.62, which suggests CBIO is a Neutral.
      What is CBIO’s MACD?
      CBIO’s MACD is -0.20, which suggests CBIO is a Sell.
        What is CBIO’s 5-day moving average?
        CBIO’s 5-day moving average is 12.98, which suggests CBIO is a Buy.
          What is CBIO’s 20-day moving average?
          CBIO 20-day moving average is 13.14, which suggests CBIO is a Sell.
            What is CBIO’s 50-day moving average?
            CBIO’s 50-day moving average is 13.12, which suggests CBIO is a Sell.
              What is CBIO’s 200-day moving average?
              CBIO’s 200-day moving average is 20.85, which suggests CBIO is a Sell.
                What is CBIO’s Williams % R (14)?
                CBIO’s Williams % R (14) is -61.46, which suggests CBIO is a Buy.
                  What is CBIO’s CCI (14)?
                  CBIO’s CCI (14) is -18.65, which suggests CBIO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis